Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Long-Term Debt Repayments (2019)

GT Biopharma (GTBP) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $100000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $100000.0 in Q1 2019 year-over-year; TTM through Dec 2019 was $100000.0, a N/A change, with the full-year FY2019 number at $100000.0, down 97.73% from a year prior.
  • Long-Term Debt Repayments was $100000.0 for Q1 2019 at GT Biopharma, up from $6000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $100000.0 in Q1 2019 to a low of $100000.0 in Q1 2019.